Zobrazeno 1 - 10
of 162
pro vyhledávání: '"B, Gelb"'
Autor:
Hyun Cheol Chung, Hendrik-Tobias Arkenau, Jeeyun Lee, Sun Young Rha, Do-Youn Oh, Lucjan Wyrwicz, Yoon-Koo Kang, Keun-Wook Lee, Jeffrey R. Infante, Sung Sook Lee, Margaret Kemeny, Ulrich Keilholz, Bohuslav Melichar, Alain Mita, Ruth Plummer, Denis Smith, Arnold B. Gelb, Huiling Xiong, Janet Hong, Vikram Chand, Howard Safran
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Abstract Background We evaluated the antitumor activity and safety of avelumab, a human anti–PD-L1 IgG1 antibody, as first-line switch-maintenance (1 L-mn) or second-line (2 L) treatment in patients with advanced gastric/gastroesophageal cancer (GC
Externí odkaz:
https://doaj.org/article/22a26bd6feb14e4185d7a995dfe688b6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jeong Hoon Ko, Neil L. Forsythe, Madeline B. Gelb, Kathryn M. M. Messina, Uland Y. Lau, Arvind Bhattacharya, Tove Olafsen, Jason T. Lee, Kathleen A. Kelly, Heather D. Maynard
Publikováno v:
Biomacromolecules. 23:3383-3395
Poly(styrenyl acetal trehalose) (pSAT), composed of trehalose side chains linked to a polystyrene backbone via acetals, stabilizes a variety of proteins and enzymes against fluctuations in temperature. A promising application of pSAT is conjugation o
Autor:
Madeline B. Gelb, Kathryn M. M. Messina, Daniele Vinciguerra, Jeong Hoon Ko, Jeffrey Collins, Mikayla Tamboline, Shili Xu, F. Javier Ibarrondo, Heather D. Maynard
Publikováno v:
ACS applied materialsinterfaces. 14(33)
Insulin, the oldest U.S. Food and Drug Administration (FDA)-approved recombinant protein and a World Health Organization (WHO) essential medicine for treating diabetes globally, faces challenges due to its storage instability. One approach to stabili
Autor:
G. Andelfinger, M. Zenker, G. Norrish, M. Russell, J. Meisner, D. Peng, T. Prendiville, J. Kleinmahon, P. Kantor, D Gottlieb Sen, D. Human, P. Ewert, M. Krueger, D. Reber, B. Donner, C. Hart, I. Odri-Komazec, S. Rupp, A. Hahn, A. Hanser, M. Hofbeck, J. Draaisma, F. Udink ten Cate, A. Mussa, G. Ferrero, L. Vaujois, M. Raboisson, M. Delrue, C. Marquis, Y. Théorêt, J. Kaski, B. Gelb, C. Wolf
Publikováno v:
Canadian Journal of Cardiology. 38:S128-S129
Autor:
Madeline B. Gelb, Ashish Punia, Shari Sellers, Parul Kadakia, James D. Ormes, Nazia N. Khawaja, Jennifer Wylie, Matthew S. Lamm
Publikováno v:
Journal of Drug Delivery Science and Technology. 68:103112
Autor:
Marie A. Printz, Lawrence Steinman, Michael C Jorge, Barry J. Sugarman, Zhongdong Huang, Gregory I. Frost, Kim Phan, Ge Wei, Chunmei Zhao, Mathieu Marella, H. Michael Shepard, Robert J. Connor, Lei Huang, Daniel C. Maneval, Jonathan Zombeck, Arnold B. Gelb, Rudolph D. Paladini, Joe Ouyang, Paula J. Lapinskas
Publikováno v:
Annals of Clinical and Translational Neurology
Objective Expression of Spam1/PH20 and its modulation of high/low molecular weight hyaluronan substrate have been proposed to play an important role in murine oligodendrocyte precursor cell (OPC) maturation in vitro and in normal and demyelinated cen
Autor:
Huiling Xiong, Do Youn Oh, Keun Wook Lee, Vikram Chand, Ruth Plummer, Sun Young Rha, Hendrik Tobias Arkenau, Denis Smith, Janet Hong, Sung Sook Lee, Yoon-Koo Kang, Lucjan Wyrwicz, Bohuslav Melichar, Arnold B. Gelb, Howard Safran, Jeeyun Lee, Alain C. Mita, Hyun Cheol Chung, Ulrich Keilholz, Jeffrey R. Infante, M. Margaret Kemeny
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Background We evaluated the antitumor activity and safety of avelumab, a human anti–PD-L1 IgG1 antibody, as first-line switch-maintenance (1 L-mn) or second-line (2 L) treatment in patients with advanced gastric/gastroesophageal cancer (GC/GEJC) pr
Autor:
Madeline B. Gelb, Heather D. Maynard
Publikováno v:
Macromol Mater Eng
Instability to storage and shipping conditions and injection administration remain major challenges in treating chronic conditions with biopharmaceuticals. Herein, formulations of poly(trehalose methacrylate) (pTrMA) were successfully optimized to st
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.